Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Lehrer-Graiwer Joshua
Relationship:   PRESIDENT AND CEO, Dir...
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   1,164,265    

Indirect Shares

  0      
Direct Value   $18,915,469    

Indirect Value

  $0      
Total Shares   1,164,265      
Total Value   $18,915,469      


Global Blood Therapeutics, Inc.
 $177,732 Lenz Therapeutics
 $18,737,737 Global Blood Therapeutics, Inc.
 $177,732 Lenz Therapeutics
 $18,737,737
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Global Blood Therapeutics, Inc. GBT Chief Medical Officer 2020-03-09 2,595 2019-11-14 0    Premium*  
            Lenz Therapeutics LENZ PRESIDENT AND CEO, Dir... 2021-06-29 1,161,670 0    Premium*  
* Premium Members only  

Records found :    32         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2020-03-05 4 AS $65.30 $74,311 D/D (1,138) 2,595 0 %
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2020-02-18 4 AS $69.71 $91,529 D/D (1,313) 2,595 0 %
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2020-02-10 4 AS $70.48 $44,050 D/D (625) 2,595 0 %
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2020-01-27 4 AS $71.15 $55,568 D/D (781) 2,016 0 %
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2020-02-06 4 AS $72.40 $285,039 D/D (3,937) 2,595 0 %
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2019-12-13 4 D $76.88 $152,530 D/D (1,984) 2,016 0 -
GBT Global Blood Therapeutics... Chief Medical Officer   •       –      –    2019-12-09 4 AS $78.50 $73,555 D/D (937) 0 0 -

  32  Records found
  1   2     
  Page 2 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed